Your browser doesn't support javascript.
Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical Trial
Clinical Complementary Medicine and Pharmacology ; : 100009, 2021.
Article in English | ScienceDirect | ID: covidwho-1509628
ABSTRACT
Backgroud The outbreak of COVID-19 has brought unprecedented perils to human health and raised public health concerns in more than two hundred countries. Safe and effective treatment scheme is needed urgently.

Objective:

To evaluate the effects of integrated TCM and western medicine treatment scheme on COVID-19.

Methods:

A single-armed clinical trial was carried out in Hangzhou Xixi Hospital, an affiliated hospital with Zhejiang Chinese Medical University. 102 confirmed cases were screened out from 725 suspected cases and 93 of them were treated with integrated TCM and western medicine treatment scheme.

Results:

83 cases were cured, 5 cases deteriorated, and 5 cases withdrew from the study. No deaths were reported. The mean relief time of fever, cough, diarrhea, and fatigue were (4.78±4.61) days, (7.22±4.99) days, (5.28± 3.39) days, and (5.28± 3.39) days, respectively. It took (14.84±5.50) days for SARS-CoV-2 by nucleic acid amplification-based testing to turn negative. Multivariable cox regression analysis revealed that age, BMI, PISCT, BPC, AST, CK, BS, and UPRO were independent risk factors for COVID-19 treatment.

Conclusion:

Our study suggested that integrated TCM and western medicine treatment scheme was effective for COVID-19.

Full text: Available Collection: Databases of international organizations Database: ScienceDirect Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Clinical Complementary Medicine and Pharmacology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ScienceDirect Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Clinical Complementary Medicine and Pharmacology Year: 2021 Document Type: Article